SCHEMBL6508985

SCHEMBL6508985

CCCCCCc1nn(CCCCc2cccc(SC(C)(C)C(=O)OCC)c2)c(=O)n(CCCC(F)(F)F)c1=O

nearest known ligand 0.40

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.40
PPARG P37231 4/20 0.40
AGTR1 P30556 1/20 0.33
AGTR2 P50052 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
ADORA3 P0DMS8 2/20 0.31
CNOT7 Q9UIV1 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509688 0.89 PPARA (0.42) PPARAPPARGAGTR1AGTR2ALDH1A1
SCHEMBL3284391 0.89 PPARA (0.38) PPARAPPARGALDH1A1ADORA3
SCHEMBL6511112 0.88 PPARA (0.42) PPARAPPARGAGTR1AGTR2ALDH1A1
SCHEMBL6511617 0.86 PPARA (0.44) PPARAPPARGAGTR1AGTR2ALDH1A1
SCHEMBL6511438 0.86 PPARA (0.60) PPARAPPARG
SCHEMBL6513058 0.86 PPARA (0.60) PPARAPPARG
SCHEMBL6512166 0.86 PPARA (0.60) PPARAPPARG
SCHEMBL6509376 0.84 PPARA (0.42) PPARAPPARGADORA3
SCHEMBL3286592 0.84 PPARA (0.41) PPARAPPARGALDH1A1HTTADORA3
SCHEMBL3284562 0.81 PPARA (0.34) PPARAPPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005080354-A1 1,2,4-TRIAZINES DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN HUMAN THERAPEUTICS PIERRE FABRE MEDICAMENT (FR) 2005-09-01 WO claimed
WO-2005080354-A1 1,2,4-TRIAZINES DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN HUMAN THERAPEUTICS PIERRE FABRE MEDICAMENT (FR) 2005-09-01 WO disclosed
WO-2005047236-A1 SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-05-26 WO disclosed